These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15259657)

  • 1. Evaluation of the new cesium-131 seed for use in low-energy x-ray brachytherapy.
    Murphy MK; Piper RK; Greenwood LR; Mitch MG; Lamperti PJ; Seltzer SM; Bales MJ; Phillips MH
    Med Phys; 2004 Jun; 31(6):1529-38. PubMed ID: 15259657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
    Li Z; Palta JR; Fan JJ
    Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
    Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
    Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription dose in permanent (131)Cs seed prostate implants.
    Yue N; Heron DE; Komanduri K; Huq MS
    Med Phys; 2005 Aug; 32(8):2496-502. PubMed ID: 16193779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo-aided dosimetry of the Symmetra model I25.S06 125I, interstitial brachytherapy seed.
    Hedtjärn H; Carlsson GA; Williamson JF
    Med Phys; 2000 May; 27(5):1076-85. PubMed ID: 10841412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose rate constant and energy spectrum of interstitial brachytherapy sources.
    Chen Z; Nath R
    Med Phys; 2001 Jan; 28(1):86-96. PubMed ID: 11213926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
    Meigooni AS; Sowards K; Soldano M
    Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental measurements of dosimetric parameters on the transverse axis of a new 125I source.
    Li Z; Fan JJ; Palta JR
    Med Phys; 2000 Jun; 27(6):1275-80. PubMed ID: 10902556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential impact of prostate edema on the dosimetry of permanent seed implants using the new 131Cs (model CS-1) seeds.
    Chen Z; Deng J; Roberts K; Nath R
    Med Phys; 2006 Apr; 33(4):968-75. PubMed ID: 16696473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose rate constant of a cesium-131 interstitial brachytherapy seed measured by thermoluminescent dosimetry and gamma-ray spectrometry.
    Chen Z; Bongiorni P; Nath R
    Med Phys; 2005 Nov; 32(11):3279-85. PubMed ID: 16372409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-estimate monte carlo calculation of the dose rate constant for a cesium-131 interstitial brachytherapy seed.
    Wittman RS; Fisher DR
    Med Phys; 2007 Jan; 34(1):49-54. PubMed ID: 17278489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
    Chiu-Tsao ST; Medich D; Munro J
    Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
    DeMarco JJ; Hugo G; Solberg TD
    Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anisotropy functions for 103Pd, 125I, and 192Ir interstitial brachytherapy sources.
    Nath R; Meigooni AS; Muench P; Melillo A
    Med Phys; 1993; 20(5):1465-73. PubMed ID: 8289730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental determination of the anisotropy function for the model 200 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model.
    Yue N; Nath R
    Med Phys; 2002 Jun; 29(6):1120-9. PubMed ID: 12094982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monte carlo investigation of the dosimetric properties of the new 103Pd BrachySeedPd-103 Model Pd-1 source.
    Chan GH; Prestwich WV
    Med Phys; 2002 Sep; 29(9):1984-90. PubMed ID: 12349919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
    Butler WM; Merrick GS; Dorsey AT; Lief JH
    Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between isotope half-life and prostatic edema for optimal prostate dose coverage in permanent seed implants.
    Villeneuve M; Leclerc G; Lessard E; Pouliot J; Beaulieu L
    Med Phys; 2008 May; 35(5):1970-7. PubMed ID: 18561673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric characterization of model Cs-1 Rev2 cesium-131 brachytherapy source in water phantoms and human tissues with MCNP5 Monte Carlo simulation.
    Wang J; Zhang H
    Med Phys; 2008 Apr; 35(4):1571-9. PubMed ID: 18491551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.